Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) had its price target decreased by stock analysts at JPMorgan Chase & Co. from $41.00 to $40.00 in a report issued on Friday, Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price indicates a potential upside of 15.67% from the stock’s current price.
KDP has been the subject of several other research reports. Wells Fargo & Company dropped their target price on shares of Keurig Dr Pepper from $43.00 to $42.00 and set an “overweight” rating for the company in a research report on Friday. Evercore ISI raised Keurig Dr Pepper to a “hold” rating in a report on Thursday, September 5th. Citigroup upgraded Keurig Dr Pepper from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $36.00 to $43.00 in a research report on Monday, September 23rd. TD Cowen upped their price target on Keurig Dr Pepper from $35.00 to $40.00 and gave the company a “hold” rating in a research report on Thursday, September 26th. Finally, Barclays lifted their price objective on shares of Keurig Dr Pepper from $37.00 to $41.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Seven research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $38.50.
Read Our Latest Analysis on KDP
Keurig Dr Pepper Trading Down 1.0 %
Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) last released its earnings results on Thursday, October 24th. The company reported $0.51 EPS for the quarter, meeting the consensus estimate of $0.51. The company had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.92 billion. Keurig Dr Pepper had a return on equity of 10.32% and a net margin of 14.47%. The business’s revenue was up 2.3% on a year-over-year basis. During the same period in the prior year, the business posted $0.48 EPS. Sell-side analysts forecast that Keurig Dr Pepper will post 1.92 EPS for the current fiscal year.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of KDP. Blue Trust Inc. boosted its position in shares of Keurig Dr Pepper by 312.1% during the second quarter. Blue Trust Inc. now owns 849 shares of the company’s stock worth $26,000 after buying an additional 643 shares during the period. Whittier Trust Co. of Nevada Inc. raised its stake in Keurig Dr Pepper by 617.1% during the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 796 shares of the company’s stock valued at $27,000 after acquiring an additional 685 shares in the last quarter. Farmers & Merchants Investments Inc. boosted its position in Keurig Dr Pepper by 51.5% during the 2nd quarter. Farmers & Merchants Investments Inc. now owns 886 shares of the company’s stock worth $30,000 after acquiring an additional 301 shares during the period. Hantz Financial Services Inc. bought a new position in shares of Keurig Dr Pepper in the second quarter worth $35,000. Finally, Riverview Trust Co acquired a new position in shares of Keurig Dr Pepper during the second quarter valued at $39,000. Institutional investors own 85.23% of the company’s stock.
Keurig Dr Pepper Company Profile
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
See Also
- Five stocks we like better than Keurig Dr Pepper
- Most active stocks: Dollar volume vs share volume
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- 3 REITs to Buy and Hold for the Long Term
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- What Does Downgrade Mean in Investing?
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.